Literature DB >> 31043682

Conjugate vaccine produces long-lasting attenuation of fentanyl vs. food choice and blocks expression of opioid withdrawal-induced increases in fentanyl choice in rats.

E Andrew Townsend1, Steven Blake2, Kaycee E Faunce1, Candy S Hwang2,3, Yoshihiro Natori2,4, Bin Zhou2, Paul T Bremer2, Kim D Janda5, Matthew L Banks6.   

Abstract

The current opioid crisis remains a significant public health issue and there is a critical need for biomedical research to develop effective and easily deployable candidate treatments. One emerging treatment strategy for opioid use disorder includes immunopharmacotherapies or opioid-targeted vaccines. The present study determined the effectiveness of a fentanyl-tetanus toxoid conjugate vaccine to alter fentanyl self-administration using a fentanyl-vs.-food choice procedure in male and female rats under three experimental conditions. For comparison, continuous 7-day naltrexone (0.01-0.1 mg/kg/h) and 7-day clonidine (3.2-10 μg/kg/h) treatment effects were also determined on fentanyl-vs.-food choice. Male and female rats responded for concurrently available 18% diluted Ensure® (liquid food) and fentanyl (0-10 μg/kg/infusion) infusions during daily sessions. Under baseline and saline treatment conditions, fentanyl maintained a dose-dependent increase in fentanyl-vs.-food choice. First, fentanyl vaccine administration significantly blunted fentanyl reinforcement and increased food reinforcement for 15 weeks in non-opioid dependent rats. Second, surmountability experiments by increasing the unit fentanyl dose available during the self-administration session 10-fold empirically determined that the fentanyl vaccine produced an approximate 22-fold potency shift in fentanyl-vs.-food choice that was as effective as the clinically approved treatment naltrexone. Clonidine treatment significantly increased fentanyl-vs.-food choice. Lastly, fentanyl vaccine administration prevented the expression of withdrawal-associated increases in fentanyl-vs.-food choice following introduction of extended 12 h fentanyl access sessions. Overall, these results support the potential and further consideration of immunopharmacotherapies as candidate treatments to address the current opioid crisis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31043682      PMCID: PMC6784909          DOI: 10.1038/s41386-019-0385-9

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  24 in total

1.  Lorcaserin maintenance fails to attenuate heroin vs. food choice in rhesus monkeys.

Authors:  E Andrew Townsend; S Stevens Negus; Justin L Poklis; Matthew L Banks
Journal:  Drug Alcohol Depend       Date:  2020-01-17       Impact factor: 4.492

2.  Vaccine blunts fentanyl potency in male rhesus monkeys.

Authors:  Rebekah D Tenney; Steven Blake; Paul T Bremer; Bin Zhou; Candy S Hwang; Justin L Poklis; Kim D Janda; Matthew L Banks
Journal:  Neuropharmacology       Date:  2019-07-29       Impact factor: 5.250

3.  Evaluation of a Dual Fentanyl/Heroin Vaccine on the Antinociceptive and Reinforcing Effects of a Fentanyl/Heroin Mixture in Male and Female Rats.

Authors:  E Andrew Townsend; Paul T Bremer; Kaycee E Faunce; S Stevens Negus; Alaina M Jaster; Hannah L Robinson; Kim D Janda; Matthew L Banks
Journal:  ACS Chem Neurosci       Date:  2020-04-22       Impact factor: 4.418

4.  Effectiveness and selectivity of a heroin conjugate vaccine to attenuate heroin, 6-acetylmorphine, and morphine antinociception in rats: Comparison with naltrexone.

Authors:  Kathryn L Schwienteck; Steven Blake; Paul T Bremer; Justin L Poklis; E Andrew Townsend; S Stevens Negus; Matthew L Banks
Journal:  Drug Alcohol Depend       Date:  2019-08-24       Impact factor: 4.492

5.  Heroin choice depends on income level and economy type.

Authors:  Tommy Gunawan; Yosuke Hachiga; Christopher S Tripoli; Alan Silberberg; David N Kearns
Journal:  Psychopharmacology (Berl)       Date:  2020-01-29       Impact factor: 4.530

6.  Lack of effect of different pain-related manipulations on opioid self-administration, reinstatement of opioid seeking, and opioid choice in rats.

Authors:  David J Reiner; E Andrew Townsend; Javier Orihuel; Sarah V Applebey; Sarah M Claypool; Matthew L Banks; Yavin Shaham; S Stevens Negus
Journal:  Psychopharmacology (Berl)       Date:  2021-03-25       Impact factor: 4.530

Review 7.  Nonhuman animal models of substance use disorders: Translational value and utility to basic science.

Authors:  Mark A Smith
Journal:  Drug Alcohol Depend       Date:  2019-11-21       Impact factor: 4.492

Review 8.  Medications Development for Treatment of Opioid Use Disorder.

Authors:  E Andrew Townsend; S Stevens Negus; Matthew L Banks
Journal:  Cold Spring Harb Perspect Med       Date:  2021-01-04       Impact factor: 6.915

Review 9.  Translational value of non-human primates in opioid research.

Authors:  Huiping Ding; Mei-Chuan Ko
Journal:  Exp Neurol       Date:  2021-01-14       Impact factor: 5.330

10.  A drug-vs-food "choice" self-administration procedure in rats to investigate pharmacological and environmental mechanisms of substance use disorders.

Authors:  E Andrew Townsend; Kathryn L Schwienteck; Hannah L Robinson; Stephen T Lawson; Matthew L Banks
Journal:  J Neurosci Methods       Date:  2021-03-08       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.